SEC EDGAR - Form 4 insider activity

Oruka Therapeutics, Inc. $ORKA

Tracked equity - 1 filings indexed by Nortis

Nortis signal thesis

Recent activity is mostly routine or balanced.

OM buys - 90d

OM sells - 90d

Routine filings

Cluster filings

$195.0K

Largest trade

10/100

Avg signal score

Filing tape

Recent filings

Last 30d: 1

Option ExerciseRoutine 10/100

filed 2026-10-02

KOCEO

Klein Lawrence Otto - Director, Chief Executive Officer - $195.0K

Option exercises are often compensation mechanics rather than a direct market view; what happens to the shares next matters more.